The Beauty Health Company (SKIN)

The Beauty Health Company Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for The Beauty Health Company stock have an average target of 2.50, with a low estimate of 1.00 and a high estimate of 5.00. The average target predicts an increase of 86.57% from the current stock price of 1.34.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$2.50	$2.00	$5.00
Change	-25.37%	+86.57%	+49.25%	+273.13%

Analyst Ratings

The average analyst rating for The Beauty Health Company stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	6	6	6	6	6	3
Sell	3	3	3	3	3	1
Strong Sell	0	0	0	0	0	0
Total	11	10	10	10	10	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Susan Anderson Canaccord Genuity	Canaccord Genuity	Hold Maintains $1.75 → $1.5	Hold	Maintains	$1.75 → $1.5	+11.94%	Mar 13, 2025
Susan Anderson Canaccord Genuity	Canaccord Genuity	Hold Maintains $1.25 → $1.75	Hold	Maintains	$1.25 → $1.75	+30.60%	Nov 13, 2024
Susan Anderson Canaccord Genuity	Canaccord Genuity	Hold Maintains $2 → $1.25	Hold	Maintains	$2 → $1.25	-6.72%	Aug 12, 2024
Korinne Wolfmeyer Piper Sandler	Piper Sandler	Sell Reiterates $1.5 → $1	Sell	Reiterates	$1.5 → $1	-25.37%	Aug 9, 2024
Jonathan Block Stifel	Stifel	Hold Maintains $4 → $2	Hold	Maintains	$4 → $2	+49.25%	Jul 26, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

340.76M

Increased by 1.93%

from 334.29M

Revenue Next Year

383.06M

Increased by 12.41%

from 340.76M

EPS This Year

-0.29

from -0.36

EPS Next Year

-0.23

from -0.29

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	119.09M	260.09M	365.88M	397.99M	334.29M	340.76M	383.06M	451.04M
Revenue Growth	-28.53%	118.39%	40.68%	8.78%	-16.01%	1.93%	12.41%	17.75%
EPS	-0.85	-3.71	-0.23	-0.76	-0.36	-0.29	-0.23	-0.28
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	10	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	370.3M	411.3M	464.3M
Avg	340.8M	383.1M	451.0M
Low	283.8M	352.8M	433.4M

Revenue Growth

Revenue Growth	2025	2026	2027
High	10.8%	20.7%	21.2%
Avg	1.9%	12.4%	17.7%
Low	-15.1%	3.5%	13.1%

EPS Forecast

EPS	2025	2026	2027
High	-0.14	-0.08	-0.26
Avg	-0.29	-0.23	-0.28
Low	-0.42	-0.34	-0.28

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.